Nevanac
Active substance: nepafenac
nepafenac
Centralised EU authorisationActive
Marketing holder: Novartis Europharm Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| US 3 |
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-2dfd-74e6-baa7-37ebde93f3a0,01a120c3-3d71-7bf4-bd5e-16f67bf16466,01a120c3-5ed7-7372-999a-45746933d576,01a120c3-6762-726a-9390-9ddbea6bf9b3,01a120c3-d35c-71c4-889d-749b6b3d7fc0;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1209a-3126-7439-b066-74a18184e442,01a1209c-5b4a-7f52-ab14-2b5404f35b7c,01a1209c-ddda-7bb7-80fe-db1450b84bf6;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000818
- Registration status
- Active
- ATC code
- S01BC10
Sources
- product · EMA · EMEA/H/C/000818 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000818 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000818 · Verified 2026-10-09